Cargando…
Twenty Years after Bovine Vaccinia in Brazil: Where We Are and Where Are We Going?
Orthopoxvirus (OPV) infections have been present in human life for hundreds of years. It is known that Variola virus (VARV) killed over 300 million people in the past; however, it had an end thanks to the physician Edward Jenner (who developed the first vaccine in history) and also thanks to a massi...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8065508/ https://www.ncbi.nlm.nih.gov/pubmed/33807254 http://dx.doi.org/10.3390/pathogens10040406 |
_version_ | 1783682357837955072 |
---|---|
author | José da Silva Domingos, Iago Silva de Oliveira, Jaqueline Lorene Soares Rocha, Kamila Bretas de Oliveira, Danilo Geessien Kroon, Erna Barbosa Costa, Galileu de Souza Trindade, Giliane |
author_facet | José da Silva Domingos, Iago Silva de Oliveira, Jaqueline Lorene Soares Rocha, Kamila Bretas de Oliveira, Danilo Geessien Kroon, Erna Barbosa Costa, Galileu de Souza Trindade, Giliane |
author_sort | José da Silva Domingos, Iago |
collection | PubMed |
description | Orthopoxvirus (OPV) infections have been present in human life for hundreds of years. It is known that Variola virus (VARV) killed over 300 million people in the past; however, it had an end thanks to the physician Edward Jenner (who developed the first vaccine in history) and also thanks to a massive vaccination program in the 20th century all over the world. Although the first vaccine was created using the Cowpox virus (CPXV), it turned out later that the Vaccinia virus was the one used during the vaccination program. VACV is the etiological agent of bovine vaccinia (BV), a zoonotic disease that has emerged in Brazil and South America in the last 20 years. BV has a great impact on local dairy economies and is also a burden to public health. In this review, we described the main events related to VACV and BV emergence in Brazil and South America, the increase of related scientific studies, and the issues that science, human and animal medicine are going to face if we do not be on guard to this virus and its disease. |
format | Online Article Text |
id | pubmed-8065508 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-80655082021-04-25 Twenty Years after Bovine Vaccinia in Brazil: Where We Are and Where Are We Going? José da Silva Domingos, Iago Silva de Oliveira, Jaqueline Lorene Soares Rocha, Kamila Bretas de Oliveira, Danilo Geessien Kroon, Erna Barbosa Costa, Galileu de Souza Trindade, Giliane Pathogens Review Orthopoxvirus (OPV) infections have been present in human life for hundreds of years. It is known that Variola virus (VARV) killed over 300 million people in the past; however, it had an end thanks to the physician Edward Jenner (who developed the first vaccine in history) and also thanks to a massive vaccination program in the 20th century all over the world. Although the first vaccine was created using the Cowpox virus (CPXV), it turned out later that the Vaccinia virus was the one used during the vaccination program. VACV is the etiological agent of bovine vaccinia (BV), a zoonotic disease that has emerged in Brazil and South America in the last 20 years. BV has a great impact on local dairy economies and is also a burden to public health. In this review, we described the main events related to VACV and BV emergence in Brazil and South America, the increase of related scientific studies, and the issues that science, human and animal medicine are going to face if we do not be on guard to this virus and its disease. MDPI 2021-03-31 /pmc/articles/PMC8065508/ /pubmed/33807254 http://dx.doi.org/10.3390/pathogens10040406 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review José da Silva Domingos, Iago Silva de Oliveira, Jaqueline Lorene Soares Rocha, Kamila Bretas de Oliveira, Danilo Geessien Kroon, Erna Barbosa Costa, Galileu de Souza Trindade, Giliane Twenty Years after Bovine Vaccinia in Brazil: Where We Are and Where Are We Going? |
title | Twenty Years after Bovine Vaccinia in Brazil: Where We Are and Where Are We Going? |
title_full | Twenty Years after Bovine Vaccinia in Brazil: Where We Are and Where Are We Going? |
title_fullStr | Twenty Years after Bovine Vaccinia in Brazil: Where We Are and Where Are We Going? |
title_full_unstemmed | Twenty Years after Bovine Vaccinia in Brazil: Where We Are and Where Are We Going? |
title_short | Twenty Years after Bovine Vaccinia in Brazil: Where We Are and Where Are We Going? |
title_sort | twenty years after bovine vaccinia in brazil: where we are and where are we going? |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8065508/ https://www.ncbi.nlm.nih.gov/pubmed/33807254 http://dx.doi.org/10.3390/pathogens10040406 |
work_keys_str_mv | AT josedasilvadomingosiago twentyyearsafterbovinevacciniainbrazilwhereweareandwherearewegoing AT silvadeoliveirajaqueline twentyyearsafterbovinevacciniainbrazilwhereweareandwherearewegoing AT lorenesoaresrochakamila twentyyearsafterbovinevacciniainbrazilwhereweareandwherearewegoing AT bretasdeoliveiradanilo twentyyearsafterbovinevacciniainbrazilwhereweareandwherearewegoing AT geessienkroonerna twentyyearsafterbovinevacciniainbrazilwhereweareandwherearewegoing AT barbosacostagalileu twentyyearsafterbovinevacciniainbrazilwhereweareandwherearewegoing AT desouzatrindadegiliane twentyyearsafterbovinevacciniainbrazilwhereweareandwherearewegoing |